VIA ONCOLOGY
Via Oncology is a national leader in decision support tools for cancer. The Via Pathways span the continuum of cancer care including workup, diagnostics, treatment, symptom management, survivorship and advance care planning. Via Oncology also supports its cancer center customers through quality reporting, patient education, clinical trial support, nurse triage and medical home tools. The Via Pathways are licensed by cancer centers in 28 states including over 1,500 oncology providers in community, hospital and academic-based settings.
VIA ONCOLOGY
Industry:
Biotechnology Health Care Hospital Medical Oncology Robotics
Founded:
2009-01-01
Address:
Pittsburgh, Pennsylvania, United States
Country:
United States
Website Url:
http://www.viaoncology.com
Total Employee:
51+
Status:
Closed
Contact:
(412) 204-1050
Technology used in webpage:
Domain Not Resolving Amazon IPv6 ASP.NET IIS Microsoft Nginx 1.14 Amazon Ohio Region Amazon Elastic Load Balancing IIS 7
More informations about "Via Oncology"
Oncology Clinical Pathways | ClinicalPath | Elsevier
When you choose ClinicalPath, your organization receives benefits unique to your partnership with Elsevier: Supports standardization of care among physicians in an increasingly complex field. Guides oncologists in their treatment decisions, …See details»
Via Oncology - Crunchbase Company Profile & Funding
Via Oncology is a national leader in decision support tools for cancer. The Via Pathways span the continuum of cancer care including workup, diagnostics, treatment, symptom management, survivorship and advance care planning. …See details»
Deliver personalized cancer care with ClinicalPath
With Elsevier’s ClinicalPath (formerly Via Oncology), you can incorporate current, evidence-based, multi-disciplinary treatment approaches to support high-quality cancer care.See details»
ClinicalPath (formerly Via Oncology) - LinkedIn
Elsevier’s ClinicalPath (formerly Via Oncology) presents evidence-based oncology pathways embedded in the clinical workflow, and the associated analytics, to help your team make consistent,...See details»
Via Oncology Company Profile 2024: Valuation, Investors
Information on acquisition, funding, investors, and executives for Via Oncology. Use the PitchBook Platform to explore the full profile.See details»
Vivacitas Oncology Inc – Bringing vision to life, together
Oct 1, 2022 · Vivacitas Oncology is a private clinical stage biopharmaceutical company focused on tough-to-treat cancers resistant to current treatment modalities. Vivacitas’ lead candidate ( AR-67) is a novel lipophilic compound …See details»
Elsevier Acquires Via Oncology, a Leading Provider of Clinical …
Jan 17, 2018 · Elsevier, the information analytics business specializing in science and health, and part of RELX Group, today announced that it has acquired Via Oncology, a Pittsburgh, …See details»
Elsevier acquires Via Oncology, a leading provider of clinical …
Elsevier, the information analytics business specializing in science and health, and part of RELX Group, today announced that it has acquired Via Oncology, a Pittsburgh, Pennsylvania-based …See details»
Elsevier Rebrands Via Oncology Clinical Pathways to ClinicalPath
Oct 11, 2019 · ClinicalPath will continue to deliver guidance to oncologists based on the latest published evidence and best practices of physicians, helping to standardize care; connect …See details»
Via Oncology Acquired by Elsevier | UPMC Enterprises
As announced Jan. 17, Elsevier, which publishes more than 2,500 digital journals, including Lancet and Cell, acquired Via Oncology – marking the first exit of a wholly owned UPMC …See details»
Via Oncology - Health IT Pittsburgh
Developer of software to support oncology healthcare practices. The software includes a platform for clinical content, oncology decision support, reports of key metrics, communications …See details»
Elsevier acquires Via Oncology, UPMC decision support spinoff
Jan 18, 2018 · Via Oncology's technology helps cancer centers demonstrate the value of their care to patients, physicians and payers by developing and implementing clinical pathways in …See details»
New study shows Elsevier’s ClinicalPath can help support …
Jun 19, 2023 · Research undertaken by Cone Health, a private not-for-profit integrated healthcare network, has shown how Elsevier’s ClinicalPath helps supported their oncologists to improve …See details»
Intermountain Healthcare Selects Elsevier's Via Oncology to …
Feb 7, 2018 · Intermountain Healthcare, a Utah -based not-for-profit integrated delivery network of hospitals, clinics, a health plan and other medical services, has selected Elsevier's Via …See details»
Use of treatment pathways reduce cost and increase entry into …
Background: VIA Oncology evidence-based pathways have been integrated into our medical oncology workflows since November 2014. Within 3 months, compliance was high for our 42 …See details»
Cancer Treatment Pathways - UPMC Hillman Cancer Center
Via Oncology is an affiliate of UPMC Hillman Cancer Center focused on the improvement of quality in cancer care through the implementation of the Via Pathways: clinical care algorithms …See details»
Development and Implementation of Oncology Care Pathways in …
With continually updated and expanding clinical content, Via Pathways has proven to be useful for physicians in providing evidence-based recommendations with the most efficacious, least …See details»
Oncology Clinical Pathways: Charting the Landscape of Pathway …
Feb 7, 2018 · It is the responsibility of the treating physician or other health care provider, relying on independent experience and knowledge of the patient, to determine drug dosages and the …See details»
Virtual visits bring big benefits for cancer care - MD Anderson …
Jan 4, 2021 · Community collaboration means better cancer care. Endocrinologist Anita Ying, M.D., treats Juan for thyroid problems related to his cancer. She says virtual visits have many …See details»
Development and Implementation of Oncology Care Pathways in …
To do this, in 2004, UPMC developed clinical pathways, a program designed to drive standardization of care around best evidence in order to measure and improve patient …See details»